Rocket Lab's Profitability Path Lengthens Under Neutron Costs and Rate Pressure

What happened

Rocket Lab faces delayed profitability due to negative incremental margins from vertical integration and high early unit costs for the Neutron rocket. The company's free cash flow remains deeply negative, with a $77.4 million burn in Q1 2026, and it has relied on $450 million in ATM equity dilution to fund operations. Rising rate hike probabilities add multiple compression headwinds for this high-growth, cash-consuming stock. To justify its current valuation, Rocket Lab would need a 30% revenue CAGR over 15 years, a growth rate achieved by very few companies. The upcoming Neutron debut, targeted for Q4 2026, is a critical catalyst, but any delay would extend the dilution runway and erode investor confidence.

Implication

Rocket Lab's path to profitability is longer and more uncertain than the market prices in, with Neutron costs and negative FCF requiring continued equity dilution. Rising interest rates could compress multiples for high-growth, unprofitable names, further pressuring the stock. The company's valuation implies an unrealistic 30% 15-year CAGR, making even a market return unlikely. While a successful Neutron launch in Q4 2026 could validate the thesis, the risk of delay is substantial given past test failures. Until the company demonstrates sustainable cash flow improvement or a clear path to profits, the stock is unattractive.

Thesis delta

The Seeking Alpha article reinforces the DeepValue report's bearish view by highlighting that Rocket Lab's profitability is delayed by negative margins from Neutron and vertical integration. The added headwind of rising rate hike probabilities amplifies multiple compression risk for this high-FCF-burn stock. This strengthens the conviction that RKLB is overvalued and a sell at current prices.